News & Updates

Bimekizumab shows promise for hidradenitis suppurativa

30 Sep 2021 by

The monoclonal IgG1 antibody bimekizumab, which selectively inhibits both interleukin(IL)-17A and 17F, demonstrated clinically meaningful improvements for moderate-to-severe hidradenitis suppurativa (HS) or acne inversa, a phase II study suggests.

Bimekizumab shows promise for hidradenitis suppurativa

30 Sep 2021

Ruxolitinib cream proven safe, effective for atopic dermatitis

29 Sep 2021 by

Application of ruxolitinib (RUX) cream for the treatment of atopic dermatitis (AD) demonstrates prompt antipruritic and anti-inflammatory effects, with superior efficacy over vehicle, according to the results from two phase III trials. RUX cream is also well-tolerated and has no safety findings suggestive of systemic Janus kinase (JAK) inhibition.

Ruxolitinib cream proven safe, effective for atopic dermatitis

29 Sep 2021

Topical permethrin plus oral ivermectin effective against common scabies

25 Sep 2021

The combination of topical permethrin and oral ivermectin is an effective treatment for common scabies, a new study has found. However, post-scabetic itch seems to persist longer than has been previously thought, particularly in older adults.

Topical permethrin plus oral ivermectin effective against common scabies

25 Sep 2021

Pooled analysis boosts guselkumab safety for psoriatic arthritis

23 Sep 2021 by

A pooled safety analysis of two phase III DISCOVER trials demonstrated the favourable safety profile of the novel interleukin(IL)-23p19-specific monoclonal antibody guselkumab through 1 year for psoriatic arthritis (PsA).

Pooled analysis boosts guselkumab safety for psoriatic arthritis

23 Sep 2021

Get vaccinated to prevent zoster recurrence, says study

05 Sep 2021

Individuals who have already experienced herpes zoster are advised to get vaccinated to avoid recurrence, suggests a study, which highlights the need for further research on immunogenicity and vaccine efficacy in this population.

Get vaccinated to prevent zoster recurrence, says study

05 Sep 2021

Biologic therapy does not heighten risk of skin, soft tissue infections

05 Sep 2021

Biologic agents do not appear to increase the risk of skin and soft tissue infections (SSTIs), a study has found. Meanwhile, concomitant use of corticosteroids heightens such risk.

Biologic therapy does not heighten risk of skin, soft tissue infections

05 Sep 2021

Immunosuppression predicts poor outcomes in Mohs-treated SCC patients

04 Sep 2021

Perineural invasion, poor differentiation, and immunosuppression are associated with poor clinical outcomes in patients with high-risk cutaneous squamous cell carcinomas (SCC), but Mohs micrographic surgery (MMS) is still an effective treatment, according to a study.

Immunosuppression predicts poor outcomes in Mohs-treated SCC patients

04 Sep 2021

Infantile skin infection ups risk of paediatric psoriasis

04 Sep 2021

Skin infections at an early age, but not antibiotic exposure, significantly contributes to the development of paediatric psoriasis, a recent study has shown.

Infantile skin infection ups risk of paediatric psoriasis

04 Sep 2021

Long-term dermatological surveillance valuable after liver transplant

30 Aug 2021 by

Though skin cancer incidence is low, liver transplant recipients may still benefit from long-term dermatological surveillance to help monitor malignancies and infections, according to a recent Singapore study.

Long-term dermatological surveillance valuable after liver transplant

30 Aug 2021

Abrocitinib induction, maintenance effective against atopic dermatitis

26 Aug 2021

Induction with abrocitinib is effective against atopic dermatitis, and continuous treatment helps suppress flares, a new trial has shown. Similarly, rescue treatment with abrocitinib in combination with topical therapy is able to recapture response.

Abrocitinib induction, maintenance effective against atopic dermatitis

26 Aug 2021

News & Updates

Filter by Specialty:

Specialty:

Bimekizumab shows promise for hidradenitis suppurativa

Bimekizumab shows promise for hidradenitis suppurativa

Ruxolitinib cream proven safe, effective for atopic dermatitis

Ruxolitinib cream proven safe, effective for atopic dermatitis

Topical permethrin plus oral ivermectin effective against common scabies

Topical permethrin plus oral ivermectin effective against common scabies

Pooled analysis boosts guselkumab safety for psoriatic arthritis

Pooled analysis boosts guselkumab safety for psoriatic arthritis

Get vaccinated to prevent zoster recurrence, says study

Get vaccinated to prevent zoster recurrence, says study

Biologic therapy does not heighten risk of skin, soft tissue infections

Biologic therapy does not heighten risk of skin, soft tissue infections

Immunosuppression predicts poor outcomes in Mohs-treated SCC patients

Immunosuppression predicts poor outcomes in Mohs-treated SCC patients

Infantile skin infection ups risk of paediatric psoriasis

Infantile skin infection ups risk of paediatric psoriasis

Long-term dermatological surveillance valuable after liver transplant

Long-term dermatological surveillance valuable after liver transplant

Abrocitinib induction, maintenance effective against atopic dermatitis

Abrocitinib induction, maintenance effective against atopic dermatitis